Semaglutide, used as an anti-diabetic and anti-obesity medication, can cut the risks of heart attacks, strokes and cardiovascular disease by 14%, the international study, of which India was a part, found Health Semaglutide, used as an anti-diabetic and anti-obesity medication, can cut the risks of heart attacks, strokes and cardiovascular disease by 14%, the international study, of which India was a part, found Sci-Tech News | Latest Technological Developments | The Hindu
Semaglutide reduces risk of cardiovascular events in patients with type 2 diabetes, finds study
